Cargando…
Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
The Calsequestrin (Csq) transgenic mouse model of cardiomyopathy exhibits wide variation in phenotypic progression dependent on genetic background. Seven heart failure modifier (Hrtfm) loci modify disease progression and outcome. Here we report Tnni3k (cardiac Troponin I-interacting kinase) as the g...
Autores principales: | Wheeler, Ferrin C., Tang, Hao, Marks, Odessa A., Hadnott, Tracy N., Chu, Pei-Lun, Mao, Lan, Rockman, Howard A., Marchuk, Douglas A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731170/ https://www.ncbi.nlm.nih.gov/pubmed/19763165 http://dx.doi.org/10.1371/journal.pgen.1000647 |
Ejemplares similares
-
Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023) -
Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene
por: Chen, Yan, et al.
Publicado: (2014) -
Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
por: Lodder, Elisabeth M., et al.
Publicado: (2012) -
Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
por: Zhao, Shane Rui, et al.
Publicado: (2021) -
Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in TNNI3 and TNNT2 That Are Common in Chinese Patients
por: Pua, Chee Jian, et al.
Publicado: (2020)